Nurix Therapeutics Inc (NRIX)
22.05
-0.32
(-1.43%)
USD |
NASDAQ |
Nov 22, 16:00
21.50
-0.55
(-2.49%)
After-Hours: 20:00
Nurix Therapeutics Total Liabilities (Quarterly): 136.74M for Aug. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 136.74M |
| May 31, 2024 | 140.34M |
| February 29, 2024 | 143.93M |
| November 30, 2023 | 155.10M |
| August 31, 2023 | 74.38M |
| May 31, 2023 | 90.70M |
| February 28, 2023 | 96.10M |
| November 30, 2022 | 113.06M |
| August 31, 2022 | 116.79M |
| May 31, 2022 | 127.57M |
| Date | Value |
|---|---|
| February 28, 2022 | 131.80M |
| November 30, 2021 | 134.47M |
| August 31, 2021 | 117.86M |
| May 31, 2021 | 119.80M |
| February 28, 2021 | 126.53M |
| November 30, 2020 | 106.07M |
| August 31, 2020 | 104.25M |
| May 31, 2020 | 106.69M |
| November 30, 2019 | 101.76M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
74.38M
Minimum
Aug 2023
155.10M
Maximum
Nov 2023
118.10M
Average
117.86M
Median
Aug 2021
Total Liabilities (Quarterly) Benchmarks
| Enzo Biochem Inc | 29.65M |
| Neogen Corp | 1.368B |
| Pfizer Inc | 126.92B |
| Zymeworks Inc | 120.17M |
| Accolade Inc | 333.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 513.60M |
| Shareholders Equity (Quarterly) | 376.86M |
| Current Ratio | 5.285 |